This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Original paper

Target therapies plus somatostatin analogs in NETs: a network meta-analysis

Volume: 28, Issue: 7, Pages: 467 - 479
Published: May 12, 2021
Abstract
Although combination therapy is not recommended in patients with gastro–entero–pancreatic (GEP) neuroendocrine tumors (NETs), this strategy is widely used in clinical practice. This network meta-analysis of randomized trials evaluates targeted therapies and somatostatin analogues in GEP-advanced NETs, either alone or in combination, comparing the efficacy of different, single or combined treatment strategies in terms of progression-free survival...
Paper Details
Title
Target therapies plus somatostatin analogs in NETs: a network meta-analysis
Published Date
May 12, 2021
Volume
28
Issue
7
Pages
467 - 479
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.